C/EBPβ-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells.


Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
07 05 2020
Historique:
received: 11 01 2019
revised: 23 08 2019
accepted: 23 01 2020
pubmed: 15 3 2020
medline: 28 4 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Hematopoietic stem cells (HSCs) maintain life-long production of immune cells and can directly respond to infection, but sustained effects on the immune response remain unclear. We show that acute immune stimulation with lipopolysaccharide (LPS) induced only transient changes in HSC abundance, composition, progeny, and gene expression, but persistent alterations in accessibility of specific myeloid lineage enhancers occurred, which increased responsiveness of associated immune genes to secondary stimulation. Functionally, this was associated with increased myelopoiesis of pre-exposed HSCs and improved innate immunity against the gram-negative bacterium P. aeruginosa. The accessible myeloid enhancers were enriched for C/EBPβ targets, and C/EBPβ deletion erased the long-term inscription of LPS-induced epigenetic marks and gene expression. Thus, short-term immune signaling can induce C/EBPβ-dependent chromatin accessibility, resulting in HSC-trained immunity, during secondary infection. This establishes a mechanism for how infection history can be epigenetically inscribed in HSCs as an integral memory function of innate immunity.

Identifiants

pubmed: 32169166
pii: S1934-5909(20)30017-5
doi: 10.1016/j.stem.2020.01.017
pii:
doi:

Substances chimiques

CCAAT-Enhancer-Binding Protein-beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

657-674.e8

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : ErratumIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Bérengère de Laval (B)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France.

Julien Maurizio (J)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France; Inovarion, 75005 Paris, France.

Prashanth K Kandalla (PK)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France; Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany.

Gabriel Brisou (G)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France.

Louise Simonnet (L)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France.

Caroline Huber (C)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France.

Gregory Gimenez (G)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France; Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtzgemeinschaft (MDC), 13125 Berlin, Germany.

Orit Matcovitch-Natan (O)

Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Susanne Reinhardt (S)

Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany.

Eyal David (E)

Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Alexander Mildner (A)

Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtzgemeinschaft (MDC), 13125 Berlin, Germany.

Achim Leutz (A)

Institute of Biology, Humboldt University of Berlin, 10115 Berlin, Germany; Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtzgemeinschaft (MDC), 13125 Berlin, Germany.

Bertrand Nadel (B)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France.

Christophe Bordi (C)

Institut de Microbiologie de la Méditerranée, CNRS, 13009 Marseille, France.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Sandrine Sarrazin (S)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France. Electronic address: sarrazin@ciml.univ-mrs.fr.

Michael H Sieweke (MH)

Aix Marseille University, CNRS, INSERM, CIML, 13009 Marseille, France; Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany; Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtzgemeinschaft (MDC), 13125 Berlin, Germany. Electronic address: michael.sieweke@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH